vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and SMITH MIDLAND CORP (SMID). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $23.1M, roughly 1.8× SMITH MIDLAND CORP). SMITH MIDLAND CORP runs the higher net margin — 9.2% vs -26.0%, a 35.2% gap on every dollar of revenue. On growth, SMITH MIDLAND CORP posted the faster year-over-year revenue change (24.7% vs -23.3%). Over the past eight quarters, SMITH MIDLAND CORP's revenue compounded faster (17.4% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Smith Midland Corp is a specialized manufacturer of precast concrete products for infrastructure, commercial, residential and industrial construction uses. Its key product lines include highway safety barriers, acoustic sound walls, architectural precast panels, and stormwater management systems, serving primarily the North American market with durable, sustainable construction solutions.

PETS vs SMID — Head-to-Head

Bigger by revenue
PETS
PETS
1.8× larger
PETS
$40.7M
$23.1M
SMID
Growing faster (revenue YoY)
SMID
SMID
+48.0% gap
SMID
24.7%
-23.3%
PETS
Higher net margin
SMID
SMID
35.2% more per $
SMID
9.2%
-26.0%
PETS
Faster 2-yr revenue CAGR
SMID
SMID
Annualised
SMID
17.4%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
SMID
SMID
Revenue
$40.7M
$23.1M
Net Profit
$-10.6M
$2.1M
Gross Margin
23.3%
57.5%
Operating Margin
-25.7%
37.8%
Net Margin
-26.0%
9.2%
Revenue YoY
-23.3%
24.7%
Net Profit YoY
-1392.6%
52.5%
EPS (diluted)
$-0.50
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
SMID
SMID
Q4 25
$40.7M
$23.1M
Q3 25
$44.4M
$21.5M
Q2 25
$51.2M
$26.2M
Q1 25
$50.8M
$22.7M
Q4 24
$52.0M
$18.5M
Q3 24
$58.0M
$23.6M
Q2 24
$66.2M
$19.6M
Q1 24
$65.1M
$16.8M
Net Profit
PETS
PETS
SMID
SMID
Q4 25
$-10.6M
$2.1M
Q3 25
$-8.5M
$2.9M
Q2 25
$-34.2M
$4.2M
Q1 25
$-11.6M
$3.3M
Q4 24
$-707.0K
$1.4M
Q3 24
$2.3M
$3.1M
Q2 24
$3.8M
$2.0M
Q1 24
$-5.0M
$1.1M
Gross Margin
PETS
PETS
SMID
SMID
Q4 25
23.3%
57.5%
Q3 25
28.0%
26.8%
Q2 25
28.1%
0.0%
Q1 25
29.9%
30.7%
Q4 24
31.0%
51.4%
Q3 24
32.3%
27.9%
Q2 24
28.8%
0.0%
Q1 24
29.3%
23.3%
Operating Margin
PETS
PETS
SMID
SMID
Q4 25
-25.7%
37.8%
Q3 25
-18.9%
18.0%
Q2 25
-66.7%
0.0%
Q1 25
-11.9%
19.3%
Q4 24
-0.9%
24.5%
Q3 24
1.0%
16.3%
Q2 24
6.6%
0.0%
Q1 24
-5.9%
9.0%
Net Margin
PETS
PETS
SMID
SMID
Q4 25
-26.0%
9.2%
Q3 25
-19.2%
13.4%
Q2 25
-66.7%
15.9%
Q1 25
-22.9%
14.7%
Q4 24
-1.4%
7.5%
Q3 24
4.0%
13.4%
Q2 24
5.7%
10.1%
Q1 24
-7.7%
6.8%
EPS (diluted)
PETS
PETS
SMID
SMID
Q4 25
$-0.50
$0.41
Q3 25
$-0.41
$0.54
Q2 25
$-1.65
$0.79
Q1 25
$-0.56
$0.62
Q4 24
$-0.03
$0.28
Q3 24
$0.11
$0.59
Q2 24
$0.18
$0.37
Q1 24
$-0.24
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
SMID
SMID
Cash + ST InvestmentsLiquidity on hand
$26.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$54.3M
Total Assets
$88.0M
$87.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
SMID
SMID
Q4 25
$26.9M
Q3 25
$36.1M
Q2 25
$41.1M
Q1 25
$54.7M
Q4 24
$50.1M
Q3 24
$52.0M
Q2 24
$46.0M
Q1 24
$55.3M
Stockholders' Equity
PETS
PETS
SMID
SMID
Q4 25
$32.8M
$54.3M
Q3 25
$43.1M
$52.1M
Q2 25
$51.5M
$49.2M
Q1 25
$85.1M
$45.1M
Q4 24
$96.2M
$41.7M
Q3 24
$96.4M
$40.3M
Q2 24
$93.5M
$37.2M
Q1 24
$96.7M
$35.3M
Total Assets
PETS
PETS
SMID
SMID
Q4 25
$88.0M
$87.7M
Q3 25
$100.3M
$85.4M
Q2 25
$109.8M
$81.2K
Q1 25
$148.7M
$74.7M
Q4 24
$144.8M
$68.0M
Q3 24
$146.0M
$66.6M
Q2 24
$152.7M
$64.0M
Q1 24
$169.9M
$64.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
SMID
SMID
Operating Cash FlowLast quarter
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
SMID
SMID
Q4 25
$-9.2M
Q3 25
$-2.2M
$11.7M
Q2 25
$-12.3M
Q1 25
$7.0M
$2.2M
Q4 24
$-1.2M
$-645.0K
Q3 24
$7.4M
$3.9M
Q2 24
$-8.5M
$2.7M
Q1 24
$7.1M
$-777.0K
Free Cash Flow
PETS
PETS
SMID
SMID
Q4 25
$-9.2M
Q3 25
$-4.8M
$6.3M
Q2 25
$-13.6M
Q1 25
$4.6M
$1.6M
Q4 24
$-1.9M
$-1.3M
Q3 24
$6.1M
$1.8M
Q2 24
$-9.2M
$998.0K
Q1 24
$5.9M
$-2.6M
FCF Margin
PETS
PETS
SMID
SMID
Q4 25
-22.7%
Q3 25
-10.8%
29.5%
Q2 25
-26.5%
Q1 25
9.1%
7.1%
Q4 24
-3.7%
-7.0%
Q3 24
10.6%
7.8%
Q2 24
-13.9%
5.1%
Q1 24
9.0%
-15.3%
Capex Intensity
PETS
PETS
SMID
SMID
Q4 25
0.1%
Q3 25
5.9%
25.1%
Q2 25
2.5%
Q1 25
4.7%
2.6%
Q4 24
1.5%
3.6%
Q3 24
2.2%
8.6%
Q2 24
1.0%
8.7%
Q1 24
1.9%
10.7%
Cash Conversion
PETS
PETS
SMID
SMID
Q4 25
Q3 25
4.07×
Q2 25
Q1 25
0.67×
Q4 24
-0.46×
Q3 24
3.18×
1.23×
Q2 24
-2.27×
1.37×
Q1 24
-0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

SMID
SMID

Product Sales$13.8M60%
Service Revenue$9.3M40%

Related Comparisons